title: Effects of eplerenone on nephrotic syndrome in a patient with renovascular hypertension.
authors.forename: Jiro
authors.initials: J
authors.lastname: Suzuki
authors.forename: Fumio
authors.initials: F
authors.lastname: Otsuka
authors.forename: Kenichi
authors.initials: K
authors.lastname: Inagaki
authors.forename: Katsuyuki
authors.initials: K
authors.lastname: Tanabe
authors.forename: Naoko
authors.initials: N
authors.lastname: Tsukamoto
authors.forename: Tomoko
authors.initials: T
authors.lastname: Miyoshi
authors.forename: Eri
authors.initials: E
authors.lastname: Nakamura
authors.forename: Toshio
authors.initials: T
authors.lastname: Ogura
authors.forename: Isao
authors.initials: I
authors.lastname: Kumagai
authors.forename: Hirofumi
authors.initials: H
authors.lastname: Makino
mesh_terms: D017311:Amlodipine / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D004095:Dihydropyridines / Q000627:therapeutic use; D000077545:Eplerenone; D006801:Humans; D006978:Hypertension, Renovascular / Q000000981:diagnostic imaging / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use*; D009404:Nephrotic Syndrome / Q000000981:diagnostic imaging / Q000188:drug therapy*; D011507:Proteinuria / Q000188:drug therapy; D011859:Radiography; D013148:Spironolactone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000959:Antihypertensive Agents; D004095:Dihydropyridines; D000451:Mineralocorticoid Receptor Antagonists; D017311:Amlodipine; D013148:Spironolactone; C061004:benidipine; D000077545:Eplerenone